Literature DB >> 15575339

Quantification of directional benefit across different polar response patterns.

Ruth A Bentler1, Jessica L M Egge, Jill L Tubbs, Andrew B Dittberner, Gregory A Flamme.   

Abstract

The purpose of this study was to assess the relationship between the directivity of a directional microphone hearing aid and listener performance. Hearing aids were fit bilaterally to 19 subjects with sensorineural hearing loss, and five microphone conditions were assessed: omnidirectional, cardioid, hypercardioid, supercardioid, and "monofit," wherein the left hearing aid was set to omnidirectional and the right hearing aid to hypercardioid. Speech perception performance was assessed using the Hearing in Noise Test (HINT) and the Connected Speech Test (CST). Subjects also assessed eight domains of sound quality for three stimuli (speech in quiet, speech in noise, and music). A diffuse soundfield system composed of eight loudspeakers forming the corners of a cube was used to output the background noise for the speech perception tasks and the three stimuli used for sound quality judgments. Results indicated that there were no significant differences in the HINT or CST performance, or sound quality judgments, across the four directional microphone conditions when tested in a diffuse field. Of particular interest was the monofit condition: Performance on speech perception tests was the same whether one or two directional microphones were used.

Entities:  

Mesh:

Year:  2004        PMID: 15575339     DOI: 10.3766/jaaa.15.9.6

Source DB:  PubMed          Journal:  J Am Acad Audiol        ISSN: 1050-0545            Impact factor:   1.664


  2 in total

1.  Directional hearing AIDS.

Authors:  T A Ricketts
Journal:  Trends Amplif       Date:  2001-12

2.  Monaural Beamforming in Bimodal Cochlear Implant Users: Effect of (A)symmetric Directivity and Noise Type.

Authors:  Elke M J Devocht; A Miranda L Janssen; Josef Chalupper; Robert J Stokroos; Erwin L J George
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.